Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 2
2016 2
2017 2
2018 2
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R. Pender MP, et al. Among authors: ioannides za. JCI Insight. 2018 Nov 15;3(22):e124714. doi: 10.1172/jci.insight.124714. JCI Insight. 2018. PMID: 30429369 Free PMC article. Clinical Trial.
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R. Pender MP, et al. Among authors: ioannides za. JCI Insight. 2020 Oct 15;5(20):e144624. doi: 10.1172/jci.insight.144624. JCI Insight. 2020. PMID: 33055421 Free PMC article. No abstract available.
The utility of FDG-PET in complex neurological conditions.
Ioannides ZA, Thomas P, Langguth D, Kubler P, Henderson RD. Ioannides ZA, et al. Intern Med J. 2017 Dec;47(12):1460-1462. doi: 10.1111/imj.13638. Intern Med J. 2017. PMID: 29224212 No abstract available.
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.
Ioannides ZA, Csurhes PA, Douglas NL, Mackenroth G, Swayne A, Thompson KM, Hopkins TJ, Green KA, Blum S, Hooper KD, Wyssusek KH, Coulthard A, Pender MP. Ioannides ZA, et al. Front Neurol. 2021 Mar 15;12:652811. doi: 10.3389/fneur.2021.652811. eCollection 2021. Front Neurol. 2021. PMID: 33790852 Free PMC article.
Anthropometric measures are not accurate predictors of fat mass in ALS.
Ioannides ZA, Steyn FJ, Henderson RD, Mccombe PA, Ngo ST. Ioannides ZA, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):486-491. doi: 10.1080/21678421.2017.1317811. Epub 2017 Apr 27. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28446030
Hypermetabolism in ALS is associated with greater functional decline and shorter survival.
Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, Heshmat S, Henders AK, Wray NR, van den Berg LH, Henderson RD, McCombe PA, Ngo ST. Steyn FJ, et al. Among authors: ioannides za. J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1016-1023. doi: 10.1136/jnnp-2017-317887. Epub 2018 Apr 29. J Neurol Neurosurg Psychiatry. 2018. PMID: 29706605 Free PMC article.
11 results